Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2012; 18(21): 2735-2738
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2735
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2735
Characteristics | Total (n = 46) | Eradication success (n = 29) | Eradication failure (n = 15) | P value |
Age (mean ± SD, yr) | 60.7 ± 12.9 | 59.8 ± 13.4 | 60.8 ± 12.1 | 0.813 |
Sex (male/female) | 26/20 | 15/14 | 10/5 | 0.530 |
Diagnosis (GU/DU/CG) | 23/15/8 | 15/10/4 | 8/3/4 | 0.450 |
Pretreatment UBT | 20.4 ± 21.2 | 14.8 ± 12.8 | 32.9 ± 28.8 | 0.019 |
Eradication rate (ITT) % | 63.0 | |||
Eradication rate (PP) % | 65.9 |
-
Citation: Nishizawa T, Suzuki H, Maekawa T, Harada N, Toyokawa T, Kuwai T, Ohara M, Suzuki T, Kawanishi M, Noguchi K, Yoshio T, Katsushima S, Tsuruta H, Masuda E, Tanaka M, Katayama S, Kawamura N, Nishizawa Y, Hibi T, Takahashi M. Dual therapy for third-line
Helicobacter pylori eradication and urea breath test prediction. World J Gastroenterol 2012; 18(21): 2735-2738 - URL: https://www.wjgnet.com/1007-9327/full/v18/i21/2735.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i21.2735